Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
Pediatrics|February 1, 2022
Off-Label Prescription of COVID-19 Vaccines in Children: Clinical, Ethical, and Legal IssuesJennifer E deSante-Bertkau, Timothy K Knilans, Govind Persad, et al.
American Journal of Public Health|June 11, 2021
Incorporating Health Equity Into COVID-19 Reopening Plans: Policy Experimentation in CaliforniaEmily A Largent, Govind Persad, Michelle M Mello, et al.
The Lancet. Infectious Diseases|July 8, 2023
The importance of getting the ethics right in a pandemic treatyG Owen Schaefer, Caesar A Atuire, Sharon Kaur, et al.
Annals of Internal Medicine|May 29, 2023
Distributional Cost-Effectiveness of Equity-Enhancing Gene Therapy in Sickle Cell Disease in the United StatesGeorge Goshua, Cecelia Calhoun, Satoko Ito, et al.
Circulation. Cardiovascular Quality and Outcomes|July 4, 2020
Can Pay-for Performance Incentive Levels be Determined Using a Cost-Effectiveness Framework?Ankur Pandya, Djøra I Soeteman, Ajay Gupta, et al.
Vaccine|July 17, 2023
Equitable global allocation of monkeypox vaccinesG Owen Schaefer, Ezekiel J Emanuel, Caesar A Atuire, et al.
Plos One|February 4, 2016
Modeling the Cost Effectiveness of Neuroimaging-Based Treatment of Acute Wake-Up StrokeAnkur Pandya, Ashley A Eggman, Hooman Kamel, et al.
JAMA|September 24, 2025
Insurance Dynamics During Childhood in the Fragmented US Health SystemYe Shen, Benjamin D Sommers, Laura A Hatfield, et al.
Radiology|September 17, 2014
Carotid artery stenosis: cost-effectiveness of assessment of cerebrovascular reserve to guide treatment of asymptomatic patientsAnkur Pandya, Ajay Gupta, Hooman Kamel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 11, 2009
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among neutropenic patients in the United StatesAmy K O'Sullivan, Ankur Pandya, George Papadopoulos, et al.
Pageof 14